After 20 years of fighting a rare blood disease, Maureen joined an MSK trial, led by Dr. Heather Landau. Dr. Karlo Perica explains how #CART therapy re-engineered her immune cells to attack the disease. Just one week after her CAR T cell infusion, Maureen’s blood tests were normal.

Every medical breakthrough begins with a decades-long journey in the lab. Our Saved by Science series, captures the emotional meetings between patients and the scientists, including MSK's Dr. David Solit, whose years of research have given them new hope. Watch on YouTube: https://bit.ly/4bRHtSe

🧬 Dr. Jungeui Hong and team at @mskcancercenter.bsky.social provide a high-level profile of the genetic features distinguishing locally advanced from metastatic PDAC, serving as a biomarker of PDACs most likely to benefit from neoadjuvant chemoradiation. https://bit.ly/4aFGZgP

After participating in an MSK clinical trial, led by gynecological oncologist Dr. Rachel Grisham & based on research by physician-scientist Dr. David Solit, Ellen, an MSK #ovariancancer patient, got early access to a treatment that has dramatically shrunk her tumors and changed her outlook on life.

Honored to be among this year's cohort of grant awardees from the @nihcm.bsky.social ! Drs. Aaron Winn, Pragya Kakani, and I will be studying trends in provider profit margins on cancer drugs. @mskcancercenter.bsky.social @ascocancer.bsky.social nihcm.org/news/nihcm-a...

Ellen was diagnosed with a rare and hard to treat #ovariancancer. Everything changed when she enrolled in a clinical trial led by Dr. Rachel Grisham, based on a lab discovery years ago by Dr. David Solit. Watch more Saved by Science stories on YouTube: https://bit.ly/3ZLODjv

🎉 Congrats to Luis Diaz Jr., MD, on receiving the 2026 Gustave Roussy Award - Honored for groundbreaking work in precision oncology. 👉https://lfdn.org/3NXPdIs #ResearchIsFundamental @mskcancercenter.bsky.social @gustaveroussy.fr

Congratulations to MSK's Dr. Luis Diaz on receiving the Gustave Roussy Prize, presented to a prominent figure whose scientific breakthroughs in cancer diagnosis, treatment, or prevention have significantly improved patient care and advanced our understanding of the disease. 👏

At #Tandem26, don't miss Dr. Mohammad Alhomoud's presentation, "Cartiac: Comparative Cardiovascular Safety of CAR T Products for Non-Hodgkin’s Lymphoma – a Propensity Score–Matched International Multicenter Study." 📍 Feb 4, 4:15 PM MST ➡️ https://bit.ly/49XCUEv @mskcancercenter.bsky.social#Tandem26

At #Tandem26, @drmiguelperales.bsky.social, MSK's Adult Bone Marrow Transplant Chief and past @astct.bsky.social President, will present research on new tools to help predict one-year survival for transplant recipients. @mskcancercenter.bsky.social 📍Feb 4, 11:15 a.m. MST ➡️ bit.ly/4tg4Rz1

Dr. Sergio Giralt is kicking off #Tandem26 for @mskcancercenter.bsky.social! Join his session to learn about the latest CAR T cell therapies for #multiplemyeloma. 📍 Feb 4, 9:05 a.m.–9:35 a.m. MST | Room 255 A-G ➡️ https://bit.ly/4rgYf25 @astct.bsky.social @cibmtr.bsky.social#Tandem26#multiplemyeloma#mmsm

Make sure to attend this great session at #tandem26 looking fwd to great talk by @mskcancercenter.bsky.social Dr Susan Dewolf and other great speakers @mskdeptofmed.bsky.social

(1/2) Neuro-oncologist Dr. Adrienne Boire teamed up with computational biologist Dr. Dana Pe’er to find a way to stop cancer cells from surviving in the cerebrospinal fluid.

MSK, in partnership with Obafemi Awolowo University, Lagos University Teaching Hospital, and Medserve, has launched a ground-breaking clinical trial aimed at transforming treatment options and standard of care for patients with #colorectalcancer in Nigeria. https://bit.ly/4qY2Iq7

New study @nature.com defining the ontogeny of Thetis cells and the developmental cues that shape their early-life wave of differentiation @mskcancercenter.bsky.social @chrysothemisbrown.bsky.social nature.com/articles/s41...

A treatment discovered through a collaboration between MSK computational biologist Dr. Dana Pe’er and MSK neuro-oncologist Dr. Adrienne Boire, has given Carlos, an MSK stage 4 #lungcancer patient, more time with his family and a much better quality of life. Watch more: https://bit.ly/4tdAmth

Just out in @nature.com: Findings from MSK researchers will facilitate future investigations of Thetis cells and efforts to harness their therapeutic potential against food allergies and autoimmune diseases. https://go.nature.com/46lMnmL

Don’t miss your opportunity to join our live CME courses this February and March. Explore full program details and register today: bit.ly/MSKCME @mskcancercenter.bsky.social

Researchers at MSK are studying the intricacies of metastatic disease to develop new ways to treat it and improve outcomes for patients with stage 4 #cancer. Learn how MSK is making progress against #metastasis.

New research from MSK sheds new light on how the gut protects itself by sensing gut bacteria; finds a subtype of #glioma-associated macrophages that appear to play a pivotal role in progression; and more.

New research at MSK shows how dormant #metastatic cancer cells prevent the immune system from eliminating them by changing their shape. The findings illuminate how cancer cells physically adapt to survive. Learn more ⬇️

#NatMetabPicks | In @cp-devcell.bsky.social led by L Studer ( @mskcancercenter.bsky.social ) Cholesterol imbalance is a common driver of neuronal dysfunction in several hPSC-derived models of major depressive disorder. 🧪 www.cell.com/developmenta...

Researchers from the lab of MSK immunologist Dr. Gretchen Diehl are shedding new light on how intestinal stem cells sense microbes and protect the gut. Read their new study, just out in @science.org #ScienceImmunology.

Congrats to Eytan Stein & collaborators on receiving "2025 Paper of the Year” from @jco-asco.bsky.social for their study evaluating revumenib for acute #leukemia with a KMT2A translocation. Study results led to the drug's FDA approval in 2024. @mskcancercenter.bsky.social#leukemia ➡️ https://bit.ly/3LH5G2R

Medical oncologist @drmiguelperales.bsky.social, Chief of the Adult Bone Marrow Transplant Service at MSK, shares 10 reasons why MSK's BMT program continues to be a leader in the field of transplantation. bit.ly/3NnAZQI

The 5-year survival rate across all cancers has reached 70%, up from 50% in 1971, according to new data from the @americancancersoc.bsky.social. Experts including @mskcancercenter.bsky.social told @statnews.com this reflects decades of sustained investment in cancer research. bit.ly/3Lsk1QI

Congratulations to Dr. Ross Levine (@rosslevinemd.bsky.social), MSK's Chief Scientific Officer, who was appointment editor-in-chief of Blood Cancer Discovery, published by @theaacr.bsky.social. Learn more: bit.ly/4qR5Qn1

Today at 12pm, we are pleased to welcome Dr. Scott Lowe @mskcancercenter.bsky.social as our #GrandRounds lecturer, presenting "Targeting the intersection between senescence and cancer." Join us in Smilow Auditorium or online via Zoom: bit.ly/49lM8u1.

🚨New Article now published at Nature Cancer 'TGFβ induces an atypical #EMT to evade #immune mechanosurveillance in #lungadenocarcinoma dormant #metastasis' ✏️By Joan Massagué and colleagues 🔗 www.nature.com/articles/s43...

Imagine a blood test that detects the first signs of a #braintumor when it might be treated more easily. A liquid biopsy for brain cancers is now one step closer to reality. The laboratory of Dr. Daniel Heller, a biomedical engineer at MSK, has developed... (cont.)

Please join us on Jan. 14th for our next #MedicalGrandRounds ! We will be joined by Eytan Stein, MD from @mskcancercenter.bsky.social for our Distinguished Alumni Lectureship sponsored by The Lewis Landsberg Society!

Coming up at #GI26, Dr. Geoffrey Ku will give a medical oncologist's perspective on the role of local and systemic treatments in metastatic #gastriccancer and #gastroesophagealcancer @mskcancercenter.bsky.social #GICancers @ascocancer.bsky.social 3:45 – 5 p.m. PST | Level 3, Room 3001

Collaborators Eric Van Cutsem, Yelena Janjigian, & Kohei Shitara caught up at #GI26. Dr. Janjigian shared a trial in progress of a 1st line combination for HER2-low #gastriccancer, gastroesophageal junction adenocarcinoma, or esophageal adenocarcinoma. @mskcancercenter.bsky.social. bit.ly/4aSddGo

MSK surgeons have extensive experience performing radical #prostatectomy and use advanced imaging and precision techniques to support safe, effective care and individualized treatment planning.

Scientists have known for decades that there are gene mutations that increase your risk of developing cancer. But there is also a genetic variant that could reduce the risk of developing certain #bloodcancers, according to new research co-led by scientists from MSK. Learn more: bit.ly/4sIJ5DQ

MSK researchers are investigating the relationship between dietary patterns and cancer. Clinical trials like #Nutrivention test how high-fiber, minimally processed plant-based food affects weight and metabolic biomarkers in people with precursor blood disorders. Learn more ⬇️

Congrats to MSK's most recent Awards & Appointments honorees, including @drvickersmsk.bsky.social for being named “61 CEO Influencers to Know” by Becker's Hospital Review, Dr. Jason Lewis for being elected as a Fellow of the National Academy of Inventors, and more: www.mskcc.org/news-release...

(1/2): HHMI Investigator Alexander Rudensky & collaborators at @mskcancercenter.bsky.social have solved a 20-year mystery: Why are high levels of regulatory #Tcells linked to better survival in colorectal cancer, when they’re usually indicative of poor outcomes in most other cancers? bit.ly/3MGn9IY

Congratulations to Dr. Deb Schrag, a gastrointestinal medical oncologist and Chair of the Department of Medicine at MSK, on being elected as the 2027-28 President of the @ascocancer.bsky.social. Read more: bit.ly/3N8Nf7q

🚨This week in @natcomms.nature.com: We resolve an enduring enigma in T cell biology—how TCR binding to p/HLA triggers intracellular signaling. CryoEM in native environment reveals a 'jack-in-the-box' mechanism! Collab btw @rockefeller.edu @mskcancercenter.bsky.social rdcu.be/eUPPl

New research from #SABCS25 suggests acupuncture may help ease “chemo brain.” 🎧 Hear Dr. Jun Mao of @mskcancercenter.bsky.social#SABCS25explain more about the results of his research on our podcast today: https://bit.ly/4pE6TH1 #BreastCancer #Breastcancerresearch

The @fda.gov approved a combination of two drugs — enfortumab vedotin and an immunotherapy drug pembrolizumab, to be given before and after surgery for people w/ muscle-invasive urothelial carcinoma — a cancer that usually starts in the bladder & can also appear in other parts of the urinary system.

Excited to share our new study, the paper is out today @cp-immunity.bsky.social! Not all Treg cells are the same. We identified two Treg cell subsets with opposing functions in colorectal cancer (CRC). 1/8

🚨 UPDATE: The @fda.gov has approved a new therapy for #marginalzonelymphoma. The approval is based on results from a phase 2 clinical trial led by Dr. Lia Palomba, a hematologist-oncologist at MSK. Learn more: bit.ly/4iVd9Y6

(1/2) Researchers from the Sloan Kettering Institute at MSK discovered that not all regulatory T cells behave the same way in tumors. Some help fight cancer, while others protect it.

Results from #SABCS25: A trial, reported by breast cancer medical oncologist @breastcancerdoc.bsky.social, show that a new treatment continues to be effective at stopping advanced #breastcancer from progressing in some people with tumors that have grown resistant to standard therapy. bit.ly/3MGgZs6

TERN-701 Elicits Deep Responses in Heavily Pretreated CP-CML @mdanderson.bsky.social @ash.hematology.org #ASH25 #leusm #oncology www.onclive.com/view/tern-70...

We're excited for AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers! @karunamdphd.bsky.social will discuss the role of pks⁺ E. coli in early-onset #colorectalcancer. @theaacr.bsky.social @mskcancercenter.bsky.social #AACRearlyonset25 TODAY | 3:20 p.m. ET bit.ly/4qlOXB1

Dr. Jun Mao, the Integrative Medicine and Wellness Service Chief at MSK, presented research on the benefits of acupuncture for #breastcancer patients who experience cancer-related cognitive impairment at the 2025 @sabcs.bsky.social . Learn more: bit.ly/4aeZAkg

#SABCS25 posters! Visit Dr. Tiffany Traina to learn about the safety analysis of first-line datopotamab deruxtecan vs chemo for locally recurrent inoperable or metastatic triple negative #breastcancer. #bcsm @sabcs.bsky.social @mskcancercenter.bsky.social ⏰ 12:30–2 p.m. CST bit.ly/4puGBqn